Novoprotein Scientific Inc. (SHA:688137)
49.54
-0.53 (-1.06%)
Apr 21, 2026, 4:00 PM EDT
Novoprotein Scientific Revenue
In the year 2025, Novoprotein Scientific had annual revenue of 151.51M CNY with 18.78% growth. Novoprotein Scientific had revenue of 39.66M in the quarter ending December 31, 2025, with 11.78% growth.
Revenue
151.51M
Revenue Growth
+18.78%
P/S Ratio
22.81
Revenue / Employee
267.69K
Employees
556
Market Cap
3.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 151.51M | 23.96M | 18.78% |
| Dec 31, 2024 | 127.56M | -25.64M | -16.73% |
| Dec 31, 2023 | 153.19M | -111.36M | -42.09% |
| Dec 31, 2022 | 264.55M | -77.34M | -22.62% |
| Dec 31, 2021 | 341.90M | 162.05M | 90.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Qingdao Vland Biotech INC. | 1.39B |
| Beijing Kawin Technology Share-Holding | 1.15B |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Cabio Biotech (Wuhan) | 574.88M |
| Shanghai Model Organisms Center | 421.26M |
| Yantai Zhenghai Biotechnology | 347.75M |
| Shanghai Shen Lian Biomedical | 288.27M |